Table 3.
Direct outpatient costs related to end stage renal disease in patients with diabetes, Brazil/2014
| Cost components | Costs per person/year (Int$)a | Total costs (Int$) |
|---|---|---|
| Dialysis (n = 32,481) | ||
| Dialysis sessions, preparation and maintenance of arteriovenous fistulas, catheter implant and removal, maintenance and accompaniment of peritoneal dialysis | 13,005 | 422,433,440 |
| Erythropoietin (77%)b | 343.8 | 8,598,298 |
| Parenteral iron (53%) | 101.5 | 1,747,310 |
| Sevelamer (40%) | 1662 | 21,602,337 |
| Calcitriol (27%) | 2595 | 8,697,590 |
| Cinacalcet (4%) | 7342 | 9,539,679 |
| Paricalcitol (3%) | 4313 | 4,203,290 |
| Medicines (weighted average) | 1033 | 54,366,108 |
| Total costs | 14,038 | 476,799,548 |
a1 Int$ = 1.74 Brazilian reais
bPercentage of use among patients on dialysis [20]